The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions
Abstract
β-Site amyloid precursor protein-cleaving enzyme-1 (BACE1) is a protease essential for amyloid-β (Aβ) production in Alzheimer's disease (AD). BACE1 protein is known to be up-regulated by oxidative stress-inducing stimuli but the mechanism for this up-regulation still needs to be clarified. We have recently found that BACE1 is modified with bisecting N-acetylglucosamine (GlcNAc) by N-acetylglucosaminyltransferase-III (GnT-III, encoded by the Mgat3 gene) and that GnT-III deficiency reduces Aβ-plaque formation in the brain by accelerating lysosomal degradation of BACE1. Therefore, we hypothesized that bisecting GlcNAc would stabilize BACE1 protein on oxidative stress. In the present study, we first show that Aβ deposition in the mouse brain induces oxidative stress, together with an increase in levels of BACE1 and bisecting GlcNAc. Furthermore, prooxidant treatment induces expression of BACE1 protein in wild-type mouse embryonic fibroblasts (MEFs), whereas it reduces BACE1 protein in GnT-III (Mgat3) knock-out MEFs by accelerating lysosomal degradation of BACE1. We purified BACE1 from Neuro2A cells and performed LC/ESI/MS analysis for BACE1-derived glycopeptides and mapped bisecting GlcNAc-modified sites on BACE1. Point mutations at two N-glycosylation sites (Asn153 and Asn223) abolish the bisecting GlcNAc modification on BACE1. These mutations almost cancelled the enhanced BACE1 degradation seen in Mgat3−/− MEFs, indicating that bisecting GlcNAc on BACE1 indeed regulates its degradation. Finally, we show that traumatic brain injury-induced BACE1 up-regulation is significantly suppressed in the Mgat3−/− brain. These results highlight the role of bisecting GlcNAc in oxidative stress-induced BACE1 expression and offer a novel glycan-targeted strategy for suppressing Aβ generation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Glycosylation has been implicated in the pathological increases in BACE1 stability seen in response to oxidative stress, with bisecting N-acetylglucosamine (GlcNAc) having been shown to prevent lysosomal degradation of BACE1.
“Glycosylation has also been implicated in the pathological increases in BACE1 stability seen in response to oxidative stress, with bisecting N‐acetylglucosamine (GlcNAc), catalyzed by GlcNAc transferase Gnt‐III having been shown to prevent lysosomal degradation of BACE1.”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [77]
Citations
Cites
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Single App knock-in mouse models of Alzheimer’s disease
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N., & Saido, T. C. (2014) · Nature Neuroscience · doi:10.1038/nn.3697 · Cited by 1,366
Self-citationKandalepas, P. C., Sadleir, K. R., Eimer, W. A., Zhao, J., Nicholson, D. A., & Vassar, R. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1152-3 · Cited by 240
Depletion of GGA1 and GGA3 Mediates Postinjury Elevation of BACE1
Walker, K. R., Kang, E. L., Whalen, M. J., Shen, Y., & Tesco, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-11.2012 · Cited by 66
Tan, J.-L., Li, Q.-X., Ciccotosto, G. D., Crouch, P. J., Culvenor, J. G., White, A. R., & Evin, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061246 · Cited by 66
Flagged first, then by citations
Research works printed but not linked: 37
- Selkoe, 2011, Resolving controversies on the path to Alzheimer's therapeutics, Nat. Med., 17, 1060, 10.1038/nm.2460 · DOI · Paper page
- Abbott, 2011, Dementia: a problem for our age, Nature, 475, S2, 10.1038/475S2a · DOI
- O’Brien, 2011, Amyloid precursor protein processing and Alzheimer's disease, Annu. Rev. Neurosci., 34, 185, 10.1146/annurev-neuro-061010-113613 · DOI · Paper page
- Vassar, 2014, Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects, J. Neurochem., 130, 4, 10.1111/jnc.12715 · DOI · Paper page
- Yang, 2003, Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease, Nat. Med., 9, 3, 10.1038/nm0103-3 · DOI · Paper page
- Loane, 2009, Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury, Nat. Med., 15, 377, 10.1038/nm.1940 · DOI · Paper page
- Kao, 2004, BACE1 suppression by RNA interference in primary cortical neurons, J. Biol. Chem., 279, 1942, 10.1074/jbc.M309219200 · DOI
- Mohmmad Abdul, 2006, Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1–42), HO and kainic acid: implications for Alzheimer's disease, J. Neurochem., 96, 1322, 10.1111/j.1471-4159.2005.03647.x · DOI
- Bains, 2012, Antioxidant therapies in traumatic brain and spinal cord injury, Biochim. Biophys. Acta, 1822, 675, 10.1016/j.bbadis.2011.10.017 · DOI
- Guglielmotto, 2009, The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha, J. Neurochem., 108, 1045, 10.1111/j.1471-4159.2008.05858.x · DOI
- Sadleir, 2012, Cdk5 protein inhibition and Abeta42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease, J. Biol. Chem., 287, 7224, 10.1074/jbc.M111.333914 · DOI
- Kizuka, 2015, An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease, EMBO Mol. Med., 7, 175, 10.15252/emmm.201404438 · DOI · Paper page
- Taniguchi, 2006, Decoding sugar functions by identifying target glycoproteins, Curr. Opin. Struct. Biol., 16, 561, 10.1016/j.sbi.2006.08.011 · DOI
- Miyoshi, 1997, Expression of alpha1–6 fucosyltransferase in rat tissues and human cancer cell lines, Int. J. Cancer, 72, 1117, 10.1002/(SICI)1097-0215(19970917)72:6<1117::AID-IJC29>3.0.CO;2-# · DOI
- Akasaka-Manya, 2010, Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer's disease, Glycobiology, 20, 99, 10.1093/glycob/cwp152 · DOI
- Kurimoto, 2014, The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function, J. Biol. Chem., 289, 11704, 10.1074/jbc.M113.502542 · DOI
- Priatel, 1997, Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction, Glycobiology, 7, 45, 10.1093/glycob/7.1.45 · DOI
- Kitazume, 2001, Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase, Proc. Natl. Acad. Sci. U.S.A., 98, 13554, 10.1073/pnas.241509198 · DOI · Paper page
- Nakano, 2008, Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers, Int. J. Cancer., 122, 2301, 10.1002/ijc.23364 · DOI
- Nakano, 2011, Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells, Mol. Cell Proteomics, 10, M111.009001, 10.1074/mcp.M111.009001 · DOI
- Mouton-Liger, 2012, Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2alpha pathway, Biochim. Biophys. Acta, 1822, 885, 10.1016/j.bbadis.2012.01.009 · DOI
- Zhang, 2009, Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development, Eur. J. Neurosci., 30, 2271, 10.1111/j.1460-9568.2009.07017.x · DOI
- Cummings, 1982, Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins, J. Biol. Chem., 257, 11230, 10.1016/S0021-9258(18)33746-3 · DOI
- Parrinello, 2003, Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts, Nat. Cell Biol., 5, 741, 10.1038/ncb1024 · DOI · Paper page
- Koh, 2005, BACE is degraded via the lysosomal pathway, J. Biol. Chem., 280, 32499, 10.1074/jbc.M506199200 · DOI
- Tesco, 2007, Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity, Neuron, 54, 721, 10.1016/j.neuron.2007.05.012 · DOI · Paper page
- Mustafa, 2010, Mitochondrial protection after traumatic brain injury by scavenging lipid peroxyl radicals, J. Neurochem., 114, 271, 10.1111/j.1471-4159.2010.06749.x · DOI
- Tamagno, 2008, Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein, J. Neurochem., 104, 683, 10.1111/j.1471-4159.2007.05072.x · DOI
- von Bernhardi, 2012, Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms, Antioxid. Redox Signal., 16, 974, 10.1089/ars.2011.4082 · DOI
- Sivanandam, 2012, Traumatic brain injury: a risk factor for Alzheimer's disease, Neurosci. Biobehav. Rev., 36, 1376, 10.1016/j.neubiorev.2012.02.013 · DOI · Paper page
- Kang, 2010, Ubiquitin regulates GGA3-mediated degradation of BACE1, J. Biol. Chem., 285, 24108, 10.1074/jbc.M109.092742 · DOI · Paper page
- Zhao, 2008, Branched N-glycans regulate the biological functions of integrins and cadherins, FEBS J., 275, 1939, 10.1111/j.1742-4658.2008.06346.x · DOI
- Taniguchi, 2011, Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics, BMB Rep., 44, 772, 10.5483/BMBRep.2011.44.12.772 · DOI
- Nishima, 2012, Effect of bisecting GlcNAc and core fucosylation on conformational properties of biantennary complex-type N-glycans in solution, J. Phys. Chem. B, 116, 8504, 10.1021/jp212550z · DOI
- Re, 2011, Structural diversity and changes in conformational equilibria of biantennary complex-type N-glycans in water revealed by replica-exchange molecular dynamics simulation, Biophys. J., 101, L44, 10.1016/j.bpj.2011.10.019 · DOI
- Schieber, 2014, ROS function in redox signaling and oxidative stress, Curr. Biol., 24, R453, 10.1016/j.cub.2014.03.034 · DOI · Paper page
- Fiala, 2007, Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin, Proc. Natl. Acad. Sci. U.S.A., 104, 12849, 10.1073/pnas.0701267104 · DOI
Cited by
Sorted by citations
Sies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520
Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Bai, R., Guo, J., Ye, X.-Y., Xie, Y., & Xie, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101619 · Cited by 813
APP mouse models for Alzheimer’s disease preclinical studies.
Sasaguri, H., Nilsson, P., Hashimoto, S., Nagata, K., Saito, T., De Strooper, B., Hardy, J., Vassar, R., Winblad, B., & Saido, T. C. (2017) · The EMBO Journal · doi:10.15252/embj.201797397 · Cited by 793
Self-citationReich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Implications of Glycosylation in Alzheimer’s Disease
Haukedal, H., & Freude, K. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.625348 · Cited by 114
BACE1: More than just a β‐secretase
Taylor, H. A., Przemylska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 107
BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease
Bao, J., Qin, M., Mahaman, Y. A. R., Zhang, B., Huang, F., Zeng, K., Xia, Y., Ke, D., Wang, Q., Liu, R., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800498115 · Cited by 50
“Previous studies indicated that BACE1 trafficking and enzymatic activity depends on acetylation or N-glycosylation (24, 43, 44).”
Background
Metadata
- Authors
- Kizuka, Y., Nakano, M., Kitazume, S., Saito, T., Saido, T. C., & Taniguchi, N.
- Affiliations
- Disease Glycomics Team, Systems Glycobiology Research Group, RIKEN–Max Planck Joint Research Centre for Systems Chemical Biology, Global Research Cluster, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Graduate School of Advanced Sciences of Matter, Hiroshima University, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 739-8530, Japan
- Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2015-12-09
- Volume
- 473
- Issue
- 1
- Pages
- 21-30
- ISSN
- 0264-6021
- 1470-8728
- Cited by
- 85
- References
- 6
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review